Depression of anticapsular antibody after immunization with Haemophilus influenzae type b polysaccharide-diphtheria conjugate vaccine
- 1 August 1989
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 8 (8) , 508-510
- https://doi.org/10.1097/00006454-198908000-00007
Abstract
Invasive Haemophilus influenzae type b infections have been observed in the week after immunization with capsular polysaccharide vaccine. We sought to document depression of antibody concentrations after immunization of 18-month-old infants with H. influenzae type b capsular polysaccharide-diphtheria conjugate vaccine. All 9 infants with detectable preimmunization anticapsular antibody had depression of antibody concentrations on the second day after immunization (P = 0.002). By Day 7 all had achieved anticapsular antibody concentrations > 0.15 .mu.g/ml, a level believed to provide protection to immediate challenge with H. influenzae type b. Of those without detectable preimmunization antibody, 7 of 21 (33%; 95% confidence interval, 11 to 56%) had not achieved concentrations of > 0.15 mg/ml 1 week after immunization. We conclude that there is depression of anticapsular antibody concentrations during the first week after immunization with H. influenzae type b capsular polysaccharide-diphtheria conjugate vaccine. We speculate that H. influenzae type b infections after immunization with H. influenzae type b vaccines may be the result of: (1) low antibody concentrations because of either depression of antibody concentrations or failure to develop antibody; and (2) exposure to H. influenzae type b. Depression of antibody concentrations could be explained by binding of in vivo antibody to the vaccine.This publication has 12 references indexed in Scilit:
- A day care-based study of the efficacy of Haemophilus b polysaccharide vaccineJAMA, 1988
- Spectrum of Disease Due to Haemophilus influenzae Type b Occurring in Vaccinated ChildrenThe Journal of Infectious Diseases, 1988
- Efficacy of Haemophilus influenzae type b capsular polysaccharide vaccineThe Pediatric Infectious Disease Journal, 1988
- Efficacy ofHaemophilus IinfluenzaeType b Polysaccharide–Diphtheria Toxoid Conjugate Vaccine in InfancyNew England Journal of Medicine, 1987
- Safety and immunogenicity of Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children 15 to 24 months of ageThe Journal of Pediatrics, 1987
- Hemophilus Influenzae Type B Disease in Children Vaccinated with Type B Polysaccharide VaccineNew England Journal of Medicine, 1986
- Safety and immunogenicity of haemophilus influenzae type b-polysaccharide diphtheria toxoid conjugate vaccine in infants 9 to 15 months of ageThe Journal of Pediatrics, 1985
- Prevention ofHemophilus influenzaeType B Bacteremic Infections with the Capsular Polysaccharide VaccineNew England Journal of Medicine, 1984
- Intrinsic Tritium Labeling of the Capsular Polysaccharide Antigen of Haemophilus Influenzae Type BThe Journal of Immunology, 1978
- HEMOPHILUS-INFLUENZAE TYPE-B CAPSULAR POLYSACCHARIDE VACCINE IN CHILDREN - DOUBLE-BLIND FIELD-STUDY OF 100,000 VACCINEES 3 MONTHS TO 5 YEARS OF AGE IN FINLAND1977